Representations are images, sounds or combinations that stand in for reality. Early forms of representation date back 32,000 years, showing an intrinsic human urge. Representations can be stereotypical or counter stereotypical, conforming to or challenging dominant ideologies. Theories suggest representations are how societies understand themselves and construct shared realities and identities, though some argue they are manipulated by those in power to maintain the status quo.
This document provides information about Dr. Eskeland's Young Tissue Extract (YTE), including what it is, its purported health benefits, and testimonials from users. YTE is a powdered protein derived from extract of healthy, pre-embryonic fertilized hen eggs. It is claimed to provide benefits such as increased sexual health, energy, stamina, muscle strength, and a sense of well-being. The extract contains amino acids and glycopeptides enriched in fertilized eggs that are said to help regulate hormones like testosterone and cortisol. Several users provide positive testimonials about increased energy, sexual function, and quality of life after taking YTE.
This document summarizes and compares different wrist-strap monitoring technologies, including impedance monitoring, voltage monitoring, and resistive loop monitoring. It then describes the features of Ohm Metrics' CM2800 series monitors in detail, which use resistive loop monitoring to measure operator resistance and ground the operator with dual wrist straps. The document discusses the CM2800 hardware components, network capabilities, software options, typical system configurations, accessories, competitors, and customer examples.
Roche claimed a patent for erlotinib in India in 2007 and marketed it under the brand name Tarceva. In 2008, Cipla planned to launch a generic version of erlotinib, which led Roche to file a patent infringement case against Cipla. Cipla argued in defense that Roche's patent was invalid because erlotinib is derived from a known cancer treatment compound, and that the large price difference between the two drugs should be considered in deciding whether to grant an interim injunction. Ultimately, in 2012 an Indian court ruled in favor of Cipla, finding that Cipla's generic version was a different polymorph variant that did not infringe Roche's patent.
The Hoven Area Right to Life and Hoven Knights of Columbus have chartered a bus to take pro-lifers from the area to attend the Hour of Reflection and Life Chain Walk in Pierre, South Dakota on January 20th. The bus will leave from the Hoven grade school parking lot at 10:30 AM and return by 5:00 PM. Suggested donations are $15 per individual or $15 per family to help cover bus costs, and bagged lunches will be provided on the ride to Pierre.
Take advantage of Hoven Area Right to Life's special convention deal for admission! This reduced rate is available only to area pro-lifers and must be made through Hoven Area Right to Life.
Representations are images, sounds or combinations that stand in for reality. Early forms of representation date back 32,000 years, showing an intrinsic human urge. Representations can be stereotypical or counter stereotypical, conforming to or challenging dominant ideologies. Theories suggest representations are how societies understand themselves and construct shared realities and identities, though some argue they are manipulated by those in power to maintain the status quo.
This document provides information about Dr. Eskeland's Young Tissue Extract (YTE), including what it is, its purported health benefits, and testimonials from users. YTE is a powdered protein derived from extract of healthy, pre-embryonic fertilized hen eggs. It is claimed to provide benefits such as increased sexual health, energy, stamina, muscle strength, and a sense of well-being. The extract contains amino acids and glycopeptides enriched in fertilized eggs that are said to help regulate hormones like testosterone and cortisol. Several users provide positive testimonials about increased energy, sexual function, and quality of life after taking YTE.
This document summarizes and compares different wrist-strap monitoring technologies, including impedance monitoring, voltage monitoring, and resistive loop monitoring. It then describes the features of Ohm Metrics' CM2800 series monitors in detail, which use resistive loop monitoring to measure operator resistance and ground the operator with dual wrist straps. The document discusses the CM2800 hardware components, network capabilities, software options, typical system configurations, accessories, competitors, and customer examples.
Roche claimed a patent for erlotinib in India in 2007 and marketed it under the brand name Tarceva. In 2008, Cipla planned to launch a generic version of erlotinib, which led Roche to file a patent infringement case against Cipla. Cipla argued in defense that Roche's patent was invalid because erlotinib is derived from a known cancer treatment compound, and that the large price difference between the two drugs should be considered in deciding whether to grant an interim injunction. Ultimately, in 2012 an Indian court ruled in favor of Cipla, finding that Cipla's generic version was a different polymorph variant that did not infringe Roche's patent.
The Hoven Area Right to Life and Hoven Knights of Columbus have chartered a bus to take pro-lifers from the area to attend the Hour of Reflection and Life Chain Walk in Pierre, South Dakota on January 20th. The bus will leave from the Hoven grade school parking lot at 10:30 AM and return by 5:00 PM. Suggested donations are $15 per individual or $15 per family to help cover bus costs, and bagged lunches will be provided on the ride to Pierre.
Take advantage of Hoven Area Right to Life's special convention deal for admission! This reduced rate is available only to area pro-lifers and must be made through Hoven Area Right to Life.
This voter guide from South Dakota Right to Life provides ratings and positions for federal and state candidates in the November 6 general election. It summarizes each candidate's stances on issues like abortion, federal funding for abortion, and healthcare regulations related to abortion and reproductive rights. Voters are encouraged to consider candidates' pro-life positions and voting records when casting their ballots.
South Dakota Right to Life provides 2011-2012 pro-life legislative ratings for South Dakota state representatives and senators. Representatives and senators received a rating from 1 (most pro-life) to 13 for representatives and 1 to 11 for senators based on their voting record and sponsorship of pro-life legislation. The document lists the ratings assigned to each representative and senator.
The document discusses the history and current state of research on fetal pain. It summarizes that in the 1970s, the prevailing view was that fetuses and newborns could not feel pain. However, research in the 1980s by the author and colleagues established the biological structures and functions necessary to feel pain were present from early in fetal development, including nociceptors, nerves, and brain structures like the thalamus processing pain signals. The document provides extensive evidence from various studies that fetuses show physiological and behavioral responses to painful stimuli from as early as 13 weeks gestation, indicating they are capable of experiencing pain.
The document discusses the evolution of pain perception and evidence that fetal pain perception may develop earlier than previously thought. It notes that by the third month of development, the fetal nervous system is developed enough to experience pain, as evidenced by studies showing fish and other early evolutionary stages can feel pain. Additional studies on fetal learning and responses to stimuli in the womb provide evidence for a level of consciousness and pain perception before the third trimester. While some research disputes these findings, the document argues that the ability to perceive and avoid harm is necessary for survival and is thus an evolved trait present early in development.
The document discusses evidence that fetuses are capable of feeling pain from as early as 8 weeks gestation. It notes that by 20 weeks gestation, the fetal brain has a full complement of neurons and EEG recordings are possible, indicating the fetus is capable of experiencing pain from 20 weeks onward. The document also discusses the gene c-fos, which is activated in response to painful stimuli and is a marker for pain in the central nervous system. Fos expression has been found in fetal bones as early as 16 weeks gestation, suggesting the fetus is capable of feeling pain from that point.
The document discusses the history and current state of research on fetal pain. It describes how in the 1970s, the prevailing view was that fetuses and newborns could not feel pain. However, research beginning in the 1980s found that fetuses have fully developed pain receptor pathways by 8 weeks gestation. It provides extensive evidence that fetuses can feel pain, including the presence of pain-sensing structures, neurotransmitters, hormonal and physiological responses to painful stimuli, and efforts to reduce fetal pain through anesthesia. The document rebuts common arguments against fetal pain such as lack of cortex, myelination, communication or memory.
The document discusses evidence for fetal pain from an evolutionary perspective. It argues that since fish feel pain, and early fetal development resembles the fish stage, fetuses may experience pain from an early stage. Studies showing that fish exhibit wariness after painful stimuli and can remember pain provide support. Further evidence discussed includes fetal learning abilities before birth, functional brain and sensory development by 20 weeks, and lack of self-harm suggesting sensation and memory. While some research has questioned fetal pain capabilities, the overall document makes a case that fetuses may experience some levels of consciousness, sensation and pain beginning fairly early in development.
The document discusses evidence that fetuses are capable of feeling pain from as early as 8 weeks gestation. It notes that by 20 weeks gestation, the fetal brain has a full complement of neurons and EEG recordings are possible, indicating the fetus is capable of experiencing pain from 20 weeks onward. The document also discusses the gene c-fos, which is activated in response to painful stimuli and is a marker for pain in the central nervous system. Fos expression has been found in fetal bones as early as 16 weeks gestation, suggesting the fetus is capable of feeling pain from that point.
This document discusses anesthesia considerations for fetal surgery. It summarizes that:
1) Fetal surgery pushes boundaries by treating the developing fetus, requiring integration of obstetric and pediatric anesthesia. Both the mother and fetus must be anesthetized.
2) Anesthetizing a pregnant woman presents challenges due to physiological changes that increase sensitivity to drugs and affect airway management, circulation, and gastric contents.
3) Fetal physiology is also complex, as neurologic pathways are still developing and the placenta acts as the organ of respiration and circulation. The effects of anesthetic agents on the developing fetus require further study.
The document appears to be an agenda for the 2011 convention of South Dakota Right to Life. The agenda lists times and topics for various sessions over the course of the convention, including discussions on informed consent, the abortion agenda, pro-life art, and grassroots organization. It also introduces several of the scheduled speakers, such as Carol Tobias and Rep. Jenna Haggar.
This voter guide from South Dakota Right to Life provides ratings and positions for federal and state candidates in the November 6 general election. It summarizes each candidate's stances on issues like abortion, federal funding for abortion, and healthcare regulations related to abortion and reproductive rights. Voters are encouraged to consider candidates' pro-life positions and voting records when casting their ballots.
South Dakota Right to Life provides 2011-2012 pro-life legislative ratings for South Dakota state representatives and senators. Representatives and senators received a rating from 1 (most pro-life) to 13 for representatives and 1 to 11 for senators based on their voting record and sponsorship of pro-life legislation. The document lists the ratings assigned to each representative and senator.
The document discusses the history and current state of research on fetal pain. It summarizes that in the 1970s, the prevailing view was that fetuses and newborns could not feel pain. However, research in the 1980s by the author and colleagues established the biological structures and functions necessary to feel pain were present from early in fetal development, including nociceptors, nerves, and brain structures like the thalamus processing pain signals. The document provides extensive evidence from various studies that fetuses show physiological and behavioral responses to painful stimuli from as early as 13 weeks gestation, indicating they are capable of experiencing pain.
The document discusses the evolution of pain perception and evidence that fetal pain perception may develop earlier than previously thought. It notes that by the third month of development, the fetal nervous system is developed enough to experience pain, as evidenced by studies showing fish and other early evolutionary stages can feel pain. Additional studies on fetal learning and responses to stimuli in the womb provide evidence for a level of consciousness and pain perception before the third trimester. While some research disputes these findings, the document argues that the ability to perceive and avoid harm is necessary for survival and is thus an evolved trait present early in development.
The document discusses evidence that fetuses are capable of feeling pain from as early as 8 weeks gestation. It notes that by 20 weeks gestation, the fetal brain has a full complement of neurons and EEG recordings are possible, indicating the fetus is capable of experiencing pain from 20 weeks onward. The document also discusses the gene c-fos, which is activated in response to painful stimuli and is a marker for pain in the central nervous system. Fos expression has been found in fetal bones as early as 16 weeks gestation, suggesting the fetus is capable of feeling pain from that point.
The document discusses the history and current state of research on fetal pain. It describes how in the 1970s, the prevailing view was that fetuses and newborns could not feel pain. However, research beginning in the 1980s found that fetuses have fully developed pain receptor pathways by 8 weeks gestation. It provides extensive evidence that fetuses can feel pain, including the presence of pain-sensing structures, neurotransmitters, hormonal and physiological responses to painful stimuli, and efforts to reduce fetal pain through anesthesia. The document rebuts common arguments against fetal pain such as lack of cortex, myelination, communication or memory.
The document discusses evidence for fetal pain from an evolutionary perspective. It argues that since fish feel pain, and early fetal development resembles the fish stage, fetuses may experience pain from an early stage. Studies showing that fish exhibit wariness after painful stimuli and can remember pain provide support. Further evidence discussed includes fetal learning abilities before birth, functional brain and sensory development by 20 weeks, and lack of self-harm suggesting sensation and memory. While some research has questioned fetal pain capabilities, the overall document makes a case that fetuses may experience some levels of consciousness, sensation and pain beginning fairly early in development.
The document discusses evidence that fetuses are capable of feeling pain from as early as 8 weeks gestation. It notes that by 20 weeks gestation, the fetal brain has a full complement of neurons and EEG recordings are possible, indicating the fetus is capable of experiencing pain from 20 weeks onward. The document also discusses the gene c-fos, which is activated in response to painful stimuli and is a marker for pain in the central nervous system. Fos expression has been found in fetal bones as early as 16 weeks gestation, suggesting the fetus is capable of feeling pain from that point.
This document discusses anesthesia considerations for fetal surgery. It summarizes that:
1) Fetal surgery pushes boundaries by treating the developing fetus, requiring integration of obstetric and pediatric anesthesia. Both the mother and fetus must be anesthetized.
2) Anesthetizing a pregnant woman presents challenges due to physiological changes that increase sensitivity to drugs and affect airway management, circulation, and gastric contents.
3) Fetal physiology is also complex, as neurologic pathways are still developing and the placenta acts as the organ of respiration and circulation. The effects of anesthetic agents on the developing fetus require further study.
The document appears to be an agenda for the 2011 convention of South Dakota Right to Life. The agenda lists times and topics for various sessions over the course of the convention, including discussions on informed consent, the abortion agenda, pro-life art, and grassroots organization. It also introduces several of the scheduled speakers, such as Carol Tobias and Rep. Jenna Haggar.